- Home
- GILD vs PANW Comparison
GILD vs PANW Comparison
Compare GILD & PANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- PANW
- Stock Information
- Founded
- GILD 1987
- PANW 2005
- Country
- GILD United States
- PANW United States
- Employees
- GILD N/A
- PANW N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- PANW Computer peripheral equipment
- Sector
- GILD Health Care
- PANW Technology
- Exchange
- GILD Nasdaq
- PANW Nasdaq
- Market Cap
- GILD 138.7B
- PANW 124.9B
- IPO Year
- GILD 1992
- PANW 2012
- Fundamental
- Price
- GILD $110.17
- PANW $196.88
- Analyst Decision
- GILD Buy
- PANW Buy
- Analyst Count
- GILD 24
- PANW 45
- Target Price
- GILD $110.95
- PANW $208.31
- AVG Volume (30 Days)
- GILD 6.3M
- PANW 4.7M
- Earning Date
- GILD 08-07-2025
- PANW 08-18-2025
- Dividend Yield
- GILD 2.87%
- PANW N/A
- EPS Growth
- GILD 1118.07
- PANW N/A
- EPS
- GILD 4.73
- PANW 1.74
- Revenue
- GILD $28,735,000,000.00
- PANW $8,874,700,000.00
- Revenue This Year
- GILD $1.69
- PANW $16.74
- Revenue Next Year
- GILD $3.67
- PANW $14.03
- P/E Ratio
- GILD $23.29
- PANW $113.07
- Revenue Growth
- GILD 4.68
- PANW 13.90
- 52 Week Low
- GILD $70.78
- PANW $142.01
- 52 Week High
- GILD $119.96
- PANW $208.39
- Technical
- Relative Strength Index (RSI)
- GILD 51.17
- PANW 52.60
- Support Level
- GILD $107.75
- PANW $194.60
- Resistance Level
- GILD $110.90
- PANW $203.20
- Average True Range (ATR)
- GILD 2.31
- PANW 4.92
- MACD
- GILD -0.38
- PANW -0.24
- Stochastic Oscillator
- GILD 33.99
- PANW 62.74
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.